Table 4.

Predictors of receipt of XR-NTX among primary care patients with alcohol use disorder^* (N = 290).

	95% CI
Factor	Odds ratio	Low	High	P-value
Predisposing
Age	1.05	1.01	1.09	0.0071
Male	0.94	0.35	2.50	0.9032
White	3.27	1.36	7.86	0.0083
Hispanic
Married/living w partner
High school education or more	1.70	0.72	4.01	0.2258
Enabling/inhibiting resources
Income over $20,000 per year
Homeless	0.39	0.14	1.06	0.0657
Working full or part-time
Ever talked to professional about alcohol use	1.10	0.44	2.71	0.8421
Received treatment for alcohol in past 12 months
PHQ8 scale for depression
Need
Co-occurring diagnosis of opioid use disorder
ER visit or overnight hospital stay in past 90 days
Negative consequences from substance use	1.14	1.04	1.26	0.0062
Received brief therapy	3.83	1.50	9.75	0.0049

Note: XR-NTX = Injectable Extended-Release Naltrexone; PHQ8 = eight-item Patient Health Questionnaire depression scale; ER = emergency room; Cl = confidence interval.

^*A11 models included site and clinical trial enrollment group.